Invention Grant
US09249207B2 Substitution mutant receptors and their use in an ecdysone receptor-based inducible gene expression system
有权
取代突变体受体及其在基于蜕皮激素受体的诱导型基因表达系统中的应用
- Patent Title: Substitution mutant receptors and their use in an ecdysone receptor-based inducible gene expression system
- Patent Title (中): 取代突变体受体及其在基于蜕皮激素受体的诱导型基因表达系统中的应用
-
Application No.: US10468192Application Date: 2002-02-20
-
Publication No.: US09249207B2Publication Date: 2016-02-02
- Inventor: Subba Reddy Palli , Marianna Zinovievna Kapitskaya
- Applicant: Subba Reddy Palli , Marianna Zinovievna Kapitskaya
- Applicant Address: US VA Blacksburg
- Assignee: Intrexon Corporation
- Current Assignee: Intrexon Corporation
- Current Assignee Address: US VA Blacksburg
- Agency: Sterne, Kessler, Goldstein & Fox, P.L.L.C.
- International Application: PCT/US02/05708 WO 20020220
- International Announcement: WO02/066615 WO 20020829
- Main IPC: C12N15/12
- IPC: C12N15/12 ; C07K14/72 ; C07K14/705
Abstract:
This invention relates to the field of biotechnology or genetic engineering. Specifically, this invention relates to the field of gene expression. More specifically, this invention relates to novel substitution mutant receptors and their use in a nuclear receptor-based inducible gene expression system and methods of modulating the expression of a gene in a host cell for applications such as gene therapy, large scale production of proteins and antibodies, cell-based high throughput screening assays, functional genomics and regulation of traits in transgenic organisms.
Public/Granted literature
Information query
IPC分类:
